NEW YORK (GenomeWeb News) - Oxford Gene Technology today said it will design an optimized oligonucleotide microarray for the Innate Discovery Team, part of the Center for IV-AIDS Vaccine Immunology.
The center will use the microarrays to study genes involved in the cellular immune response of early-stage HIV-infected patients.
OGT said the microarrays will be printed using its ink jet in situ synthesis platform for parallel analysis of multiple samples.
Financial terms of the agreement were not released.